Phytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus - current status.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
diabetes mellitus 4 endocrinologydiseases
diabetic neuropathy 1 endocrinologydiseases
diabetic retinopathy 1 endocrinologydiseases
hyperlipidemia 1 endocrinologydiseases
obesity 3 endocrinologydiseases
type 2 diabetes mellitus 2 endocrinologydiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
diabetes mellitus 123 Journal of NanomedicinePhytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus – current statusPalanivel GanesanPalanisamy ArulselvanDong-Kug Choi1Nanotechnology Research Center
diabetes mellitus 596 Serdang, MalaysiaPublication date (collection): /2017Publication date (epub): 2/2017AbstractType 2 diabetes mellitus (T2DM) is a major chronic disease that is prevalent worldwide, and it is characterized by an increase
diabetes mellitus 2130 nanotechnological delivery to ensure a highly efficient treatment of type 2 diabetes.IntroductionType 2 diabetes mellitus (T2DM) is a major chronic disease with an increasing prevalence worldwide, and it is a major burden
diabetes mellitus 33977 improve the bioavailability of genistein in many chronic diseases, but the applicability to type 2 diabetes mellitus animal model is still limited.Nano-hesperidinHesperidin is another phyto-derived flavonoid compound
diabetic neuropathy 25303 delivery system was developed, has a particle size of ~213 nm, and has shown improved protection of diabetic neuropathy through oral delivery systems in male Sprague Dawley rats.[152] Several other nanodelivery systems have
diabetic retinopathy 27134 hollow silicate nanocarriers were studied for their efficacy in treating angiogenesis associated with diabetic retinopathy . The NPs, with an average mean size of ~400 nm, showed higher efficacy in delivery and greater protective
hyperlipidemia 30510 hepatoprotective activity was also reported for morin in certain studies, which indicated it can reduce hyperlipidemia . In addition, morin has an insulin-mimetic effect, and it is widely accepted to be a naturally derived
obesity 2504 factors, including genetics, age, lack of physical activity, food habits, high stress, inflammation, and obesity . Many factors related to this disease can be controlled through a change in lifestyle and activities.[3],[4]
obesity 27362 characteristics against angiogenesis.[170] Emodin-loaded nano-transferosome was also studied against obesity , a causative factor for T2DM. The size of emodin loaded nano-transferosome was of ~292 nm with encapsulation
obesity 27557 nm with encapsulation efficacy of ~69%, and these showed a relatively higher effect in terms of anti obesity activity,[171] which is an alternative approach to reduce the risk for T2DM. A few other nanodelivery
type 2 diabetes mellitus 116 International Journal of NanomedicinePhytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus – current statusPalanivel GanesanPalanisamy ArulselvanDong-Kug Choi1Nanotechnology Research Center
type 2 diabetes mellitus 33970 out to improve the bioavailability of genistein in many chronic diseases, but the applicability to type 2 diabetes mellitus animal model is still limited.Nano-hesperidinHesperidin is another phyto-derived flavonoid compound

You must be authorized to submit a review.